ENCell Co., Ltd.

ENCell Co., Ltd. develops cell and gene-based biopharmaceutical products in South Korea. Its lead program, EN00, is an allogeneic mesenchymal stem cell therapy derived from umbilical cord tissue for Charcot-Marie-Tooth disease. The company also provides contract development and manufacturing services for biopharmaceutical products. Founded in 2018, ENCell is based in Seoul, South Korea.